MOONLAKE IMMUNOTHERAPEUTICS Effective Income Tax Rate Reconciliation, Deduction, Other, Percent
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) reported Effective Income Tax Rate Reconciliation, Deduction, Other, Percent of 0.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther · last filed 2025-02-26
- MOONLAKE IMMUNOTHERAPEUTICS effective income tax rate reconciliation, deduction, other, percent for fiscal 2024 was 0.00%.
- MOONLAKE IMMUNOTHERAPEUTICS effective income tax rate reconciliation, deduction, other, percent for fiscal 2023 was 0.00%, a 100.00% decline from fiscal 2022.
- MOONLAKE IMMUNOTHERAPEUTICS effective income tax rate reconciliation, deduction, other, percent for fiscal 2022 was 0.50%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Other, Percent 10 month | Effective Income Tax Rate Reconciliation, Deduction, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Deduction, Other, Percent 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | 0.00% 10-K · filed 2025-02-26 | ||
| 2023-12-31 | 0.00% 10-K · filed 2025-02-26 | ||
| 2022-12-31 | 0.50% 10-K · filed 2025-02-26 | -0.50% 10-K · filed 2023-03-20 | |
| 2021-12-31 | 0.10% 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |